Evidence map›Paper›PMID 22347459›Full record

ArticlePloS one2012

Homing and long-term engraftment of long- and short-term renewal hematopoietic stem cells.

Liansheng Liu, Elaine F Papa, Mark S Dooner, Jason T Machan, Kevin W Johnson, Laura R Goldberg, Peter J Quesenberry, Gerald A Colvin

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Enhanced hematopoietic stem cell self-renewal and engraftment through human lung exosomal communication.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Adult stem cell niches for tissue homeostasis.Journal of cellular physiology · 2022
    Review
  5. Article
  6. Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  7. Article
  8. Safety and efficacy of ex vivo expanded CD34Stem cell research & therapy · 2019
    Article
  9. Hematopoietic Stem Cell Heterogeneity.Advances in experimental medicine and biology · 2019
    Review
  10. Cell Cycle Regulation of Stem Cells by MicroRNAs.Stem cell reviews and reports · 2018
    Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liansheng LiuDepartment of Medicine, Division of Hematology/Oncology, Rhode Island Hospital, Providence, Rhode Island, United States of America.
Elaine F Papa
Mark S Dooner
Jason T Machan
Kevin W Johnson
Laura R Goldberg
Peter J Quesenberry
Gerald A Colvin

Funding

COBRE for Skeletal Health and RepairP20GM104937 · NIGMS · RHODE ISLAND HOSPITAL · PI CHEN, QIAN · 2012 to 2016
$10.8M
TYORISINE PHOSPHATASE SHP2 IN HEMATOPOIETIC STEM CELL PROPERTY MAINTENANCEP20RR025179 · NCRR · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2009 to 2011
$6.4M
Minimal Treatment Models of Stem Cell EngraftmentR01DK061858 · NIDDK · ROGER WILLIAMS HOSPITAL · PI QUESENBERRY, PETER J · 2001 to 2004
$1.7M
Stem/Progenitor Cell Inversions With Cell Cycle TransitK08DK064980 · NIDDK · ROGER WILLIAMS HOSPITAL · PI COLVIN, GERALD ALEXANDER · 2003 to 2007
$627k
NCRR NIH HHS P20 RR025179NIDDK NIH HHS K08 DK064980NIDDK NIH HHS R01 DK061858NIGMS NIH HHS P20 GM104937
6 · The paper itself

Abstract

Long-term hematopoietic stem cells (LT-HSC) and short-term hematopoietic stem cells (ST-HSC) have been characterized as having markedly different in vivo repopulation, but similar in vitro growth in liquid culture. These differences could be due to differences in marrow homing. We evaluated this by comparing results when purified ST-HSC and LT-HSC were administered to irradiated mice by three different routes: intravenous, intraperitoneal, and directly into the femur. Purified stem cells derived from B6.SJL mice were competed with marrow cells from C57BL/6J mice into lethally irradiated C57BL/6J mice. Serial transplants into secondary recipients were also carried out. We found no advantage for ST-HSC engraftment when the cells were administered intraperitoneally or directly into femur. However, to our surprise, we found that the purified ST-HSC were not short-term in nature but rather gave long-term multilineage engraftment out to 387 days, albeit at a lower level than the LT-HSC. The ST-HSC also gave secondary engraftment. These observations challenge current models of the stem cell hierarchy and suggest that stem cells are in a continuum of change.

Indexed as

Graft SurvivalAnimalsBone MarrowCell ProliferationFemurHematopoietic Stem Cell TransplantationMiceTime Factors

Identifiers

PMID22347459
PMCPMC3276536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.